208 related articles for article (PubMed ID: 29079526)
1. Synergistic enhancement of topotecan-induced cell death by ascorbic acid in human breast MCF-7 tumor cells.
Sinha BK; van 't Erve TJ; Kumar A; Bortner CD; Motten AG; Mason RP
Free Radic Biol Med; 2017 Dec; 113():406-412. PubMed ID: 29079526
[TBL] [Abstract][Full Text] [Related]
2. Elucidation of Mechanisms of Topotecan-Induced Cell Death in Human Breast MCF-7 Cancer Cells by Gene Expression Analysis.
Sinha BK; Tokar EJ; Bushel PR
Front Genet; 2020; 11():775. PubMed ID: 32765594
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis.
Bruzzese F; Rocco M; Castelli S; Di Gennaro E; Desideri A; Budillon A
Mol Cancer Ther; 2009 Nov; 8(11):3075-87. PubMed ID: 19887547
[TBL] [Abstract][Full Text] [Related]
4. The effect of Topotecan on oxidative stress in MCF-7 human breast cancer cell line.
Timur M; Akbas SH; Ozben T
Acta Biochim Pol; 2005; 52(4):897-902. PubMed ID: 16273129
[TBL] [Abstract][Full Text] [Related]
5. The effect of quercetin on topotecan cytotoxicity in MCF-7 and MDA-MB 231 human breast cancer cells.
Akbas SH; Timur M; Ozben T
J Surg Res; 2005 May; 125(1):49-55. PubMed ID: 15836850
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of topoisomerase I poisoning by a camptothecin analog.
Staker BL; Hjerrild K; Feese MD; Behnke CA; Burgin AB; Stewart L
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15387-92. PubMed ID: 12426403
[TBL] [Abstract][Full Text] [Related]
7. Reactive oxygen species generated from the reaction of copper(II) complexes with biological reductants cause DNA strand scission.
Ueda J; Takai M; Shimazu Y; Ozawa T
Arch Biochem Biophys; 1998 Sep; 357(2):231-9. PubMed ID: 9735163
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan.
Sorensen M; Sehested M; Jensen PB
Br J Cancer; 1995 Aug; 72(2):399-404. PubMed ID: 7640225
[TBL] [Abstract][Full Text] [Related]
9. Topotecan-triggered degradation of topoisomerase I is p53-dependent and impacts cell survival.
Tomicic MT; Christmann M; Kaina B
Cancer Res; 2005 Oct; 65(19):8920-6. PubMed ID: 16204064
[TBL] [Abstract][Full Text] [Related]
10. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
Li Y; Kuppusamy P; Zweir JL; Trush MA
Mol Pharmacol; 1996 Mar; 49(3):412-21. PubMed ID: 8643080
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction between topotecan and microtubule-interfering agents.
Bahadori HR; Green MR; Catapano CV
Cancer Chemother Pharmacol; 2001 Sep; 48(3):188-96. PubMed ID: 11592339
[TBL] [Abstract][Full Text] [Related]
12. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
[TBL] [Abstract][Full Text] [Related]
13. Phenoxyl radical-induced thiol-dependent generation of reactive oxygen species: implications for benzene toxicity.
Stoyanovsky DA; Goldman R; Claycamp HG; Kagan VE
Arch Biochem Biophys; 1995 Mar; 317(2):315-23. PubMed ID: 7893144
[TBL] [Abstract][Full Text] [Related]
14. Redox modifications of cysteine-containing proteins, cell cycle arrest and translation inhibition: Involvement in vitamin C-induced breast cancer cell death.
El Banna N; Hatem E; Heneman-Masurel A; Léger T; Baïlle D; Vernis L; Garcia C; Martineau S; Dupuy C; Vagner S; Camadro JM; Huang ME
Redox Biol; 2019 Sep; 26():101290. PubMed ID: 31412312
[TBL] [Abstract][Full Text] [Related]
15. Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cells.
Hu Y; Krishan A; Nie W; Sridhar KS; Mayer LD; Bally M
Clin Cancer Res; 2004 Feb; 10(3):1160-9. PubMed ID: 14871996
[TBL] [Abstract][Full Text] [Related]
16. From Lead to Drug Utilizing a Mannich Reaction: The Topotecan Story.
Bracher F; Tremmel T
Arch Pharm (Weinheim); 2017 Jul; 350(7):. PubMed ID: 27805723
[TBL] [Abstract][Full Text] [Related]
17. Pro-oxidative vs antioxidative properties of ascorbic acid in chromium(VI)-induced damage: an in vivo and in vitro approach.
Poljsak B; Gazdag Z; Jenko-Brinovec S; Fujs S; Pesti M; Bélagyi J; Plesnicar S; Raspor P
J Appl Toxicol; 2005; 25(6):535-48. PubMed ID: 16092082
[TBL] [Abstract][Full Text] [Related]
18. Formation of reactive oxygen species and DNA strand breakage during interaction of chromium (III) and hydrogen peroxide in vitro: evidence for a chromium (III)-mediated Fenton-like reaction.
Tsou TC; Yang JL
Chem Biol Interact; 1996 Dec; 102(3):133-53. PubMed ID: 9021167
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects.
Molavian HR; Goldman A; Phipps CJ; Kohandel M; Wouters BG; Sengupta S; Sivaloganathan S
Sci Rep; 2016 Jun; 6():27439. PubMed ID: 27278439
[TBL] [Abstract][Full Text] [Related]
20. Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex.
Mancini G; D'Annessa I; Coletta A; Sanna N; Chillemi G; Desideri A
PLoS One; 2010 Jun; 5(6):e10934. PubMed ID: 20532182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
